Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank 
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs 
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom 
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver 
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries” 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
John Ternus Signals Apple’s Future with Product-First AI Strategy 
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic 
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility 
Want to cut your energy bills? Here’s how five experts are doing it 
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe 
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns 
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed 
SOMERSET, N.J., March 11, 2016 -- MTBC (NASDAQ:MTBC), a leading provider of proprietary, healthcare information technology solutions today announced that its e-prescribing tool has been awarded the prestigious 2015 White Coat of Quality by Surescripts for clinical quality excellence in e-prescribing.
This award, which MTBC has achieved three times, bolsters its e-prescribing products and highlights its commitment to continue to train its users. “MTBC is pleased to have been awarded this recognition by Surescripts,” said Hadi Chaudhry, MTBC Chief Information Officer. He added, “MTBC’s development team is devoted to building quality solutions that assist providers in their practice and this recognition is evidence of that commitment.”
This achievement recognizes MTBC for upholding the highest standards of prescription content quality in e-prescribing. In addition, this year MTBC released its pioneering electronic prescribing Smartwatch app for Apple Watch users. Including this new app, MTBC now has over seven other mHealth apps in its suite. One of the most popular apps continues to be the MTBC ICD-10 converter app, which has consistently been the converter app of choice for providers across the nation, available for both Android and Apple devices.
To learn more about MTBC, please visit www.mtbc.com.
About Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.”
For additional information, please visit our website at www.mtbc.com.
Follow MTBC on TWITTER, LINKEDIN and FACEBOOK.
Press Contact: Amritpal Deol, Vice President and General Counsel MTBC [email protected] (732) 873-5133 x 141
